SANUWAVE Health, Inc. (SNWV)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | 8-K (2026-07-13) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-12) · 99.1 | 8-K (2026-04-16) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-26) · 99.1 | 8-K (2025-11-07) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-08-08) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-07-14) · 99.1 | 8-K (2025-05-09) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-04-08) · 99.1 | 8-K (2025-03-21) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-01-14) · 99.1 | 8-K (2024-11-08) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-08-13) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-07-10) · 99.1 | 8-K (2024-05-10) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-04-10) · 99.1 | 8-K (2024-03-22) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-01-10) · 99.1 | 8-K (2023-11-13) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-10-10) · 99.1 | 8-K (2023-08-11) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Document and Entity Information | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Condensed Consolidated Statements of Comprehensive (loss) Income | — |
|
| Condensed Consolidated Statements of Comprehensive (loss)/income | — |
|
| Consolidated Statements of Comprehensive Loss | ||
| Condensed Consolidated Statements of Comprehensive Income (loss) (P) | — |
|
| Consolidated Statements of Comprehensive Income (loss) | ||
| Consolidated Statements of Stockholders' Deficit | ||
| Consolidated Statements of Stockholders' Equity (deficit) | ||
| Consolidated Statements of Cash Flows | ||
| Condensed Consolidated Statements of Comprehensive Loss (P) | ||
| Condensed Consolidated Statements of Stockholders' Deficit (P) | ||
| Notes | ||
| Accounts Payable and Accrued Expenses | ||
| Accrued Expenses | ||
| Allowance For Credit Losses | ||
| Asset-backed Secured Promissory Notes | ||
| Award Timing Disclosure | — |
|
| Commitments and Contingencies | ||
| Common Stock | — |
|
| Common Stock Purchase Warrants | — |
|
| Concentration of Credit Risk and Limited Suppliers | ||
| Concentration of Limited Suppliers | — |
|
| Contract Liabilities | — |
|
| Convertible Promissory Notes and Convertible Promissory Notes, Related Parties | — |
|
| Convertible Promissory Notes Payable | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Factoring Liabilities | — |
|
| Fair Value Measurements | ||
| Going Concern | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | — |
|
| Inventory | ||
| Leases | ||
| License and Option Agreement | ||
| Long Term Debt, Revolving Credit Facility and Senior Secured Debt | ||
| Loss Per Share | ||
| Merger Agreement | ||
| Nature of The Business and Basis of Presentation | ||
| Net (loss) Income Per Share | — |
|
| Net Income (loss) Per Share | ||
| Net Loss Per Share | — |
|
| Pay Vs Performance Disclosure | ||
| Promissory Notes Payable | ||
| Property and Equipment | ||
| Restatement of 2025 and 2024 Quarterly Financial Information (unaudited) | — |
|
| Restatement of Previously Issued Financial Statements | ||
| Revenue | ||
| Segment Information | ||
| Senior Secured Debt | ||
| Senior Secured Debt, In Default | ||
| Stock-based Compensation | ||
| Subsequent Event | ||
| Summary of Significant Accounting Policies | ||